Pharmacokinetics of intraocular drug delivery of oregon green 488-labeled triamcinolone by subtenon injection using ocular fluorophotometry in rabbit eyes

Investigative Ophthalmology and Visual Science

Volumn 49, Issue 10, 2008, Pages 4506-4514

  Lee, Sung Jin ^a,b   Kim, Esther S ^b   Geroski, Dayle H ^b   McCarey, Bernard E ^b   Edelhauser, Henry F ^b,c  

^a Soonchunhyang University   (South Korea)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCENT DYE; OREGON GREEN 488; TRIAMCINOLONE ACETONIDE; UNCLASSIFIED DRUG; CARBOXYLIC ACID; GLUCOCORTICOID; OREGON GREEN 488 CARBOXYLIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOROID; CHOROID VASCULARIZATION; CONJUNCTIVA; CONTROLLED STUDY; DRUG DIFFUSION; DRUG PENETRATION; EX VIVO STUDY; EYE; FLUORESCENCE; FLUORESCENCE MICROSCOPY; FLUOROMETRY; FLUOROPHOTOMETRY; HISTOLOGY; IN VIVO STUDY; NONHUMAN; PERFUSION; PRIORITY JOURNAL; RABBIT; RETINA; SCLERA; STEADY STATE; ANIMAL; ANTERIOR EYE SEGMENT; CONNECTIVE TISSUE; DRUG DELIVERY SYSTEM; INJECTION; METABOLISM; METHODOLOGY; PERMEABILITY; VITREOUS BODY;

ANIMALS; ANTERIOR EYE SEGMENT; CARBOXYLIC ACIDS; CHOROID; CONNECTIVE TISSUE; DRUG DELIVERY SYSTEMS; FLUORESCENT DYES; FLUOROPHOTOMETRY; GLUCOCORTICOIDS; INJECTIONS; MICROSCOPY, FLUORESCENCE; PERMEABILITY; RABBITS; RETINA; SCLERA; TRIAMCINOLONE ACETONIDE; VITREOUS BODY;

EID: 53449087071     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-1989     Document Type: Article

References (32)

1. Beer PM, Bakri SJ, Singh RJ, et al. Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. Ophthalmology. 2003;110:681-686. (Pubitemid 36520063)
2. Tano Y, Chandler D, Machemer R. Treatment of intraocular proliferation with intravitreal injection of triamcinolone acetonide. Am J Ophthalmol. 1980;90:810-816. (Pubitemid 11199134)
3. Martis A, Duker JS, Greenberg PB, et al. Intravitreal triamcinolone acetonide for refractory diabetic macular edema. Ophthalmology. 2007;109:920-927.
4. Kok H, Lau C, Maycock N, et al. Outcome of intravitreal triamcinolone in uveitis. Ophthalmology. 2005;112(11):1916.e1-7
5. Ruiz-Moreno JM, Montero JA, Zarbin MA. Photodynamic therapy and high-dose intravitreal triamcinolone to treat exudative age-related macular degeneration: 2-year outcome. Retina. 2007;27:458-461. (Pubitemid 46624286)
6. Nelson ML, Tennant MT, Sivalingam A, et al. Infectious and presumed noninfectious endophthalmitis after intravitreal triamcinolone acetonide injection. Retina. 2004;138:489-492.
7. Ozkiris A, Erkilic K. Complications of intravitreal injection of triamcinolone acetonide. Can J Ophthalmol. 2005;40:63-68. (Pubitemid 40470519)
8. Choi YJ, Oh IK, Oh JR, Huh K. Intravitreal versus posterior subtenon injection of triamcinolone acetonide for diabetic macular edema. Korean J Ophthalmol. 2006;20:205-209.
9. Cardillo JA, Melo LA, Costa RA, et al. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema. Ophthalmology. 2005;112:1557-1563. (Pubitemid 41725412)
10. Inoue M, Takeda K, Morita K, Yamada M, Tanigawara Y, Oguchi Y. Vitreous concentrations of triamcinolone acetonide in human eyes after intravitreal or subtenon injection. Am J Ophthalmol. 2004;138:1046-1048. (Pubitemid 40040025)
11. Mora P, Eperon S, Felt-Baeyens O, et al. Trans-scleral diffusion of triamcinolone acetonide. Curr Eye Res. 2005;30:355-361.
12. Robinson MR, Lee SS, Kim H, et al. A rabbit model for assessing the ocular barriers to the transscleral delivery of triamcinolone acetonide. Exp Eye Res. 2006;82:479-487. (Pubitemid 43138962)
13. Weijtens O, Feron EJ, Schoemaker RC, et al. High concentration of dexamethasone in aqueous and vitreous after subconjunctival injection. Am J Ophthalmol. 1999;128:192-197. (Pubitemid 29379772)
14. Weijtens O, Schoemaker RC, Cohen AF, et al. Dexamethasone concentration in vitreous and serum after oral administration. Am J Ophthalmol. 1998;125:673-679. (Pubitemid 28265516)
15. Weijtens O, van der Sluijs FA, Schoemaker RC, et al. Peribulbar corticosteroid injection: vitreal and serum concentrations after dexamethasone disodium phosphate injection. Am J Ophthalmol. 1997;123:358-363. (Pubitemid 27123042)
16. Weijtens O, Schoemaker RC, Lentjes EG, et al. Dexamethasone concentration in the subretinal fluid after a subconjunctival injection, a peribulbar injection, or an oral dose. Ophthalmology. 2000;107:1932-1938. (Pubitemid 30769639)
17. Ghate D, Brooks W, McCarey BE, Edelhauser HF. Pharmacokinetics of intraocular drug delivery by periocular injections using ocular fluorophotometry. Invest Ophthalmol Vis Sci. 2007;48:2230-2237. (Pubitemid 351261299)
18. Song L, Hennink EJ, Young IT, Tnake HJ. Photobleaching kinetics of fluorescein in quantitative fluorescence microscopy. Biophys J. 1995;68:2588-2600.
19. Sjoback R, Nygren J, Kubista M. Characterization of fluorescein- oligonucleotide conjugates and measurement of local electrostatic potential. Biopolymers. 1998;46:445-453. (Pubitemid 28536552)
20. Grady LT, Hays SE, King RH, et al. Drug purity profiles. J Pharm Sci. 1973;62:456-464.
21. Thomas ER, Wang J, Ege E, Mdsen R, Haisworth DP. Intravitreal triamcinolone acetonide concentration after subtenon injection. Am J Ophthalmol. 2006;142:860-861. (Pubitemid 44584127)
22. Kao JC, Geroski DH, Edelhauser HF. Transscleral permeability of fluorescent-labeled antibiotics. J Ocul Pharmacol Ther. 2005;21:1-10.
23. Cruysberg LPJ, Nuijts RMMA, Geroski DH, et al. In vitro human sclera permeability of fluorescein, dexamethasone-fluorescein, methotrexate- fluorescein, and rhodamine 6G and the use of a coated coil as a new drug delivery system. J Ocul Phamacol Ther. 2002;18:559-569.
24. Kim H, Robinson MR, Lizak MJ, et al. Controlled drug release from an ocular implant: an evaluation using dynamic three-dimensional magnetic resonance imaging. Invest Ophthalmol Vis Sci. 2004;45:2722-2731. (Pubitemid 38998870)
25. Mason JO 3rd, Somaiya MD, Singh RJ. Intravitreal concentration and clearance of triamcinolone acetonide in nonvitrectomized human eyes. Retina. 2004;24:900-904.
26. Chin HS, Park TS, Moon YS, Oh JH. Difference in clearance of intravitreal triamcinolone acetonide between vitrectomized and nonvitrectomized eyes. Retina. 2005;25:556-560.
27. Bodker FS, Ticho BH, Feist RM, Lam TT. Intraocular dexamethasone penetration via subconjunctival or retrobulbar injections in rabbits. Ophthalmic Surg. 1993;24:453-457. (Pubitemid 23202891)
28. Barry A, Rousseau A, Babineau LM. The penetration of steroids into the rabbit's vitreous, choroid and retina following retrobulbar injection. I. Can J Ophthalmol. 1969;4:365-369.
29. Alm A, Bill A. Ocular and optic nerve flow at normal and increased intraocular pressures in monkeys (Macaca irus): a study with radioactively labeled microspheres including flow determinations in brain and some other tissues. Exp Eye Rex. 1973;15:15-29.
30. Bill A, Stjernschantz J. Cholinergic vasoconstrictor effects in the rabbit eye: vasomotor effects of pentobarbital anesthesia. Acta Physiol Scand. 1980;108:419-424. (Pubitemid 10120199)
31. Boulton M, Flessner M, Armstrong D, et al. Lymphatic drainage of the CNS: effects of lymphatic diversion/ligation on CSF protein transport to plasma. Am J Physiol. 1997;272:1613-1619. (Pubitemid 27240664)
32. Deak ST, Scaky TZ. Factors regulating the exchange of nutrients and drugs between lymph and blood in the small intestine. Microcirc Endothelium Lymphat. 1984;1:569-588.